Data as of Apr 16
| +0.06 / +0.44%|
The 9 analysts offering 12-month price forecasts for Amedisys Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 6.00. The median estimate represents a -20.00% decrease from the last price of 13.75.
The current consensus among 11 polled investment analysts is to Sell stock in Amedisys Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.